The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary fibrosis
Publications
Tobacco smoking and risk for pulmonary fibrosis: A prospective cohort study in UK Biobank.
Chest 2021 Apr 24;; — 2021 Apr 24
Abramson MJ, Murambadoro T, Alif SM, Benke GP, Dharmage SC, Glaspole I, Hopkins P, Hoy RF, Klebe S, Moodley Y, Rawson S, Reynolds PN, Wolfe R, Corte TJ, Walters EH,
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
Thorax 2020 Oct;75;864-869 — 2020 Oct — 864-869
Tobacco smoke-induced lung fibrosis and emphysema.
Annual review of physiology 2014;76;493-513 — 2014 — 493-513
Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases.
Journal of clinical pathology 2013 Oct;66;882-7 — 2013 Oct — 882-7
Smoking-related interstitial lung diseases.
Clinics in chest medicine 2012 Mar;33;165-78 — 2012 Mar — 165-78
Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.
Thorax 2007 Oct;62;904-10 — 2007 Oct — 904-10
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 1997 Jan;155;242-8 — 1997 Jan — 242-8